Merit Medical Systems, Inc. has announced the appointment of Martha Aronson as the new President and Chief Executive Officer, effective October 3, 2025. Fred P. Lampropoulos will continue to serve as the Chairman of the Board, President, and CEO until that date.
Martha Aronson brings extensive experience in global healthcare, having overseen healthcare businesses ranging from $500 million to $1 billion. She has held executive positions at Ecolab, Inc., Hill-Rom Holdings, Inc., and Medtronic, as well as serving on the boards of various companies. With a background in economics and a Master of Business Administration from Harvard Business School, she is well-equipped to lead Merit Medical Systems into the future.
Preliminary unaudited revenue for the quarter ended June 30, 2025, is projected to be in the range of approximately $380 to $384 million, representing a 12% to 14% increase compared to the same period in 2024. Furthermore, the constant currency revenue for the same period is expected to increase by approximately 11% to 13% compared to the prior year.
Founded in 1987, Merit Medical Systems, Inc. develops, manufactures, and distributes proprietary disposable medical devices used in various medical procedures. The company serves hospitals globally with a sales force and clinical support team totaling more than 800 individuals and employs approximately 7,300 people worldwide. The market has reacted to these announcements by moving the company's shares -1.76% to a price of $93.49. If you want to know more, read the company's complete 8-K report here.
